Nalaganje...
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme
BACKGROUND: Elderly patients with metastatic melanoma have different disease characteristics and a poorer prognosis than younger patients. Data from clinical trials and expanded access programmes (EAPs) suggest ipilimumab confers a consistent survival benefit and has a similar safety profile across...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3996509/ https://ncbi.nlm.nih.gov/pubmed/24708900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-33-30 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|